Geneos Wealth Management Inc. Has $1.91 Million Stake in Cardinal Health, Inc. $CAH

Key Points

• Geneos Wealth Management Inc. reduced its stake in Cardinal Health, Inc. by 22.5%, owning 13,854 shares valued at $1.91 million at the end of the last quarter.
• Insider activity included a sale of 38,078 shares by insider Jessica L. Mayer and a sale of 35,901 shares by CEO Jason M. Hollar, indicating significant insider trading in recent weeks.
• The company reported earnings of $2.08 EPS for the last quarter, surpassing analyst expectations, and announced a quarterly dividend of $0.5107 per share.

Geneos Wealth Management Inc. cut its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 22.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,854 shares of the company's stock after selling 4,030 shares during the quarter. Geneos Wealth Management Inc.'s holdings in Cardinal Health were worth $1,909,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CAH. Wellington Management Group LLP grew its stake in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after buying an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the period. GAMMA Investing LLC boosted its position in Cardinal Health by 17,589.1% during the first quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock worth $132,940,000 after purchasing an additional 959,486 shares during the period. Zurich Insurance Group Ltd FI boosted its position in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock worth $130,434,000 after purchasing an additional 927,950 shares during the period. Finally, Nuveen LLC bought a new position in Cardinal Health during the first quarter worth $106,065,000. 87.17% of the stock is owned by institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares of the company's stock, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Price Performance

CAH stock traded down $1.16 during midday trading on Tuesday, reaching $149.11. The company had a trading volume of 1,232,980 shares, compared to its average volume of 2,385,573. The company has a market capitalization of $35.61 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44. The stock has a 50 day moving average price of $154.16 and a 200-day moving average price of $148.08.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is presently 31.63%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of recent research reports. Bank of America boosted their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Argus set a $189.00 target price on shares of Cardinal Health in a research report on Friday, August 22nd. Evercore ISI reduced their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research report on Wednesday, August 13th. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.